Pillstats
Rx only · Tablet · Oral

Fluoxetine

Fluoxetine Hydrochloride

3 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US5 NDCs
3 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)4493
US makers3 labelers
Packages16
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 6 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.024$0.048$0.072$0.096Dec 2025Apr 2026Jul 2026
$0.081
Latest avg · Jul 22, 2026
+1%
Since Dec 17, 2025
3
Active US suppliers
94%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

20K40K60K80K2025 Q12025 Q22025 Q32025 Q42026 Q1
47K
Rx · 2026 Q1
2.1M
Units dispensed
+1535%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it3 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Torrent Pharmaceuticals Limitedunknown10SUPPLYING
Strides Pharma Science Limitedunknown5SUPPLYING
Bryant Ranch Prepackrepackager1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • May 27, 2025
    RECALLRecall (Class II): Fluoxetine Tablets, USP, 20 mg, 28-count Carton (4x7 Unit-dose), Manufactured by: TORRENT PHARMACEUTIALS LTD., Indrad-3…

    CGMP Deviations: Presence of N-Nitroso Fluoxetine exceeding interim acceptable intake limit. — Recalling firm: Torrent Pharma Inc. — U.S. Nationwide.

  • May 27, 2025
    RECALLRecall (Class II): Fluoxetine Tablets, USP, 20 mg, 30-count bottle, Rx only, Manufactured by: TORRENT PHARMACEUTIALS LTD., Indrad-382 721…

    CGMP Deviations: Presence of N-Nitroso Fluoxetine exceeding interim acceptable intake limit. — Recalling firm: Torrent Pharma Inc. — U.S. Nationwide.